OrphAI Therapeutics Announces Appointment of Jay Fine to Board of Directors
24 janv. 2024 10h38 HE
|
OrphAI Therapeutics Inc.
GUILFORD, Conn., Jan. 24, 2024 (GLOBE NEWSWIRE) -- OrphAI Therapeutics Inc. (“OrphAI”), a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today...